The Claim
Omega-3 fatty acid supplementation reduces triglyceride levels by a mean difference of 35.55 mg/dL in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis, taking omega-3 fatty acid supplements lowers blood triglyceride levels by an average of 35.55 mg/dL.
See the scientific wording
Omega-3 fatty acid supplementation significantly reduces triglyceride levels by a mean difference of 35.55 mg/dL in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis, indicating a beneficial effect on hepatic lipid metabolism.
Omega-3 fatty acids enter liver cells and turn on two special switches called PPARα and PPARγ. PPARα makes the liver burn more fat for energy, while PPARγ improves how the body responds to insulin, which stops the liver from making new fat. Together, these actions reduce the amount of fat stored in the liver and released into the blood.
What the research says
1 studyStudy: Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
This study found that taking omega-3 supplements lowers triglyceride levels in people with fatty liver disease, which means it helps reduce harmful fats in the blood and possibly in the liver too.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.